Maxion raises $72M in series A, advancing MAX-001
·
May 17, 2025
Media
Maxion raises $72M in series A, advancing MAX-001
NewsMaxion raises $72M in series A, advancing MAX-001
The Works, Suite 4 — Unity Campus
London Road
Cambridge, CB22 3FT
United Kingdom
Registered office address: c/o Mishcon de Reya, Africa House, 70 Kingsway WC2B 6AH London United Kingdom Company Reg. Number: 12560803
Copyright © 2024 Maxion Therapeutics Ltd.
